Immunotherapy News and Research

Latest Immunotherapy News and Research

New immunotherapy target found in pancreatic cancer cells

Researchers from MIT and Dana-Farber Cancer Institute have discovered that a class of peptides expressed in pancreatic cancer cells could be a promising target for T-cell therapies and other approaches that attack pancreatic tumors.

8 May 2025

Next-generation "armored" CAR T cell therapy shows promising results in lymphoma patients

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas continued to resist multiple rounds of other cancer treatments, including commercially available CAR T cell therapies.

8 May 2025

Understanding the psychological toll of asthma or allergies

People who have struggled with asthma or allergies for years understand the psychological toll of these conditions.

7 May 2025

Immunotherapy before and after surgery boost longer event-free survival in head and neck cancer

Patients with locally advanced head and neck cancer who received the immune checkpoint inhibitor pembrolizumab before, during and after standard-of-care surgery had longer event-free survival without the cancer coming back and higher rates of substantial tumor shrinkage prior to surgery, according to the first interim analysis of a randomized, open-label phase 3 clinical trial led by investigators from Dana-Farber Brigham Cancer Center and Washington University School of Medicine in St. Louis.

6 May 2025

Five major advances in anal and rectal cancer treatment with radiotherapy: A new era of organ-preserving options

Rectal cancer is a type of bowel cancer that develops in the last several centimeters of the large intestine, just before the anus.

2 May 2025

New antibody design enhances immune system's ability to fight cancer

Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease.

1 May 2025

Immunotherapy replaces surgery for early-stage dMMR cancers in landmark study

Neoadjuvant PD-1 blockade with dostarlimab achieved high rates of organ preservation in patients with early-stage mismatch repair-deficient (dMMR) solid tumors across multiple types. Most patients avoided surgery with durable disease control, reshaping potential cancer treatment pathways.

28 Apr 2025

Humanized antibody dismantles metabolic barrier as a potential cancer immunotherapy

A Ludwig Cancer Research study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.

28 Apr 2025

UQ begins first human trial of immunotherapy for Type 1 diabetes

Researchers at The University of Queensland have dosed 5 participants in the first clinical trial of a potentially revolutionary immunotherapy drug to treat Type 1 diabetes.

28 Apr 2025

New topical gel reduces painful rash from colorectal cancer treatment

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 significantly reduces the severity of an acne-like rash, a common and painful side effect experienced by patients undergoing anti-EGFR therapies for colorectal cancer.

28 Apr 2025

Pre and post-surgical immunotherapy improves survival in head and neck cancer patients

27 Apr 2025

Dana-Farber experts present innovative cancer studies at the 2025 AACR Annual Meeting

Numerous studies conducted by researchers at Dana-Farber Cancer Institute report progress for cancers including head and neck cancer, metastatic breast cancer and lung cancer.

27 Apr 2025

MD Anderson researchers present promising clinical trial results at AACR 2025

Researchers from The University of Texas MD Anderson Cancer Center will present promising results from clinical trials in three minisymposia abstracts at the American Association for Cancer Research (AACR) Annual Meeting 2025.

26 Apr 2025

Bruker to launch Beacon Discovery™ at AACR 2025, expanding access to live single-cell functional analysis

Bruker Corporation today announced the launch of the Beacon Discovery™ Optofluidic System at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2025.

From Bruker Cellular Analysis 25 Apr 2025

Novel cancer immunotherapy approach could complement existing CAR-T treatments

Researchers in South Korea have proposed a novel cancer immunotherapy approach that could complement existing CAR-T (Chimeric Antigen Receptor T-cell) treatments.

24 Apr 2025

AI tools improve detection of key immune structures in melanoma

Researchers from the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) have applied AI-driven processes for detecting tertiary lymphoid structures (TLS) in thousands of digital images of melanoma tumor tissue, significantly enhancing TLS identification and survival predictions for operable stage III/IV patients.

24 Apr 2025

lncRNAs shape the tumor microenvironment and drive cancer development

The tumor microenvironment (TME) is a complex and dynamic network consisting of tumor cells, immune cells, stromal cells, extracellular matrix (ECM), cytokines, and growth factors, all interacting to influence tumorigenesis, progression, and metastasis.

24 Apr 2025

Immunotherapy News and Research

Latest Immunotherapy News and Research

New immunotherapy target found in pancreatic cancer cells

Next-generation "armored" CAR T cell therapy shows promising results in lymphoma patients

Understanding the psychological toll of asthma or allergies

Immunotherapy before and after surgery boost longer event-free survival in head and neck cancer

Five major advances in anal and rectal cancer treatment with radiotherapy: A new era of organ-preserving options

New antibody design enhances immune system's ability to fight cancer

Immunotherapy replaces surgery for early-stage dMMR cancers in landmark study

Humanized antibody dismantles metabolic barrier as a potential cancer immunotherapy

UQ begins first human trial of immunotherapy for Type 1 diabetes

New topical gel reduces painful rash from colorectal cancer treatment

Pre and post-surgical immunotherapy improves survival in head and neck cancer patients

Dana-Farber experts present innovative cancer studies at the 2025 AACR Annual Meeting

MD Anderson researchers present promising clinical trial results at AACR 2025

Bruker to launch Beacon Discovery™ at AACR 2025, expanding access to live single-cell functional analysis

Novel cancer immunotherapy approach could complement existing CAR-T treatments

AI tools improve detection of key immune structures in melanoma

lncRNAs shape the tumor microenvironment and drive cancer development

Manipulating a master regulator prevents tumor growth in mice

Exploring the role of immune checkpoints IDO1 and PDL1 in Cutaneous Leishmaniasis (CL)

Daily peanut doses help adults overcome severe allergies

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Immunotherapy News and Research

Latest Immunotherapy News and Research

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Newsletters you may be interested in